Search Breaking New Ground Our Science Our Therapy Areas About Us MedImmune Translational Science Forum convenes leaders from the Bay area to discuss advancing precision medicine in drug development PUBLISHED 23 May 2016 Share Mountain View, Ca., May 23, 2016 – Today, key leaders from academia, industry, government and funding organizations in and around the San Francisco Bay Area will convene for the MedImmune California Translational Science Forum to discuss innovative approaches to address precision medicine’s big data challenges and opportunities in bioinformatics and drug discovery. Notable program speakers will include: , Senior Health Advisor, Governor’s Office of Planning and Research and , Founder and Chief Technology Officer, Definiens (Nobel Laureate). Important notice for users You are about to access MedImmune historic archive material. Any reference in these archives to MedImmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. I disagree I agree ?

Search Breaking New Ground Our Science Our Therapy Areas About Us AstraZeneca to strengthen presence in California with new south San Francisco location PUBLISHED 27 September 2016 Share Move will create scientific site for more than 350 local employees GAITHERSBURG, MD., September 27, 2016 – AstraZeneca, together with its global biologics research and development arm MedImmune, today revealed plans to bring together five of its Bay Area sites into one location in South San Francisco. The new site will be located in the Cove at Oyster Point with cutting-edge lab space and offices. More than 350 employees in existing AstraZeneca, Acerta Pharma, MedImmune, and Pearl R&D facilities will move to the new location beginning in Q4 2017. Important notice for users You are about to access MedImmune historic archive material. Any reference in these archives to MedImmune products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes. I disagree I agree ?